Does the Use of the Dermabond Prineo Skin Closure System Decrease Wound Breakdown in Breast Reduction Patients?

Goals/Purpose:

Dermabond Prineo Skin Closure System is a relatively new

product manufactured by Ethicon which utilizes a self-adhering mesh that is

applied to the approximated skin edges to provide temporary skin edge

alignment and a liquid topical skin adhesive is applied over the mesh to

achieve skin closure. It is intended to hold closed easily approximated

skin edges of wounds from surgical incisions. It is intended to be used in

conjuction with deep dermal sutures and has been shown to have the benefit of

reducing final closure time by as much as 75%. This product was used at our

facility by one surgeon for all of the patients undergoing breast reductions.

Methods/Technique:

This study is a retrospective chart review. A single surgeons

breast reduction cases were pulled for a consecutive 2 year period.

Exclusion criteria was prior history of breast cancer, prior breast

rediction, or any radiation to the chest previously. Demographic data

,pre-operative data, operative and post-operative data, as well as

complications were collected.

Results/Complications:

There was a total of 30 patients who had been closed with the

Dermabond Prineo Skin Closure System and 24 patients closed without the

system. The age, race, BMI and schnur scores, as well as resection scores

were similar across these two groups. It was noted that wound dehiscence,

with respect to the T-Zone region occurred in 66.66% of patient’s who had

closure with sutures alone versus 20% % in patients who had been closed

with the Dermabond Prineo device. It was also noted that patients who were

smokers, had Diabetes, were on anticoagulants were more likely to have

wound healing problems despite the use of the closure device.

Conclusion:

The Dermabond Prineo Skin Closure System significantly reduced wound dehiscence. It is a safe and efficacious product to use.